SILKGRAFT — SILK VASCULAR PROSTOHESIS (Q2043362): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
||
description / en | description / en | ||
Project in Italy | Project Q2043362 in Italy | ||
description / it | description / it | ||
Progetto in Italia | Progetto Q2043362 in Italia |
Revision as of 09:57, 2 November 2020
Project Q2043362 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | SILKGRAFT — SILK VASCULAR PROSTOHESIS |
Project Q2043362 in Italy |
Statements
12,500.0 Euro
0 references
25,000.0 Euro
0 references
50.0 percent
0 references
12 July 2017
0 references
30 March 2018
0 references
26 July 2018
0 references
SILK BIOMATERIALS S.R.L.
0 references
Q285743 (Deleted Item)
0 references
SILK BIOMATERIALS (SILK) STA SVILUPPANDO SILKGRAFT - SILK VASCULAR PROSTHESIS (SVP), UN DISPOSITIVO PER LA RIGENERAZIONE IN VIVO DI VASI SANGUIGNI CON DIAMETRO (I.D.)<8MM. I VASI SANGUIGNI SONO LA COMPONENTE DEL SISTEMA CIRCOLATORIO CHE CONSENTE IL TRASPORTO DI OSSIGENO E NUTRIENTI A TESSUTI E ORGANI, E LA RIMOZIONE DI CO2 E CATABOLITI. I PRINCIPALI VASI SANGUIGNI DI MEDIO/PICCOLO CALIBRO (CORONARIE, ARTERIE PERIFERICHE E CAROTIDI) POSSONO INCORRERE IN PATOLOGIE CHE NE RICHIEDONO LA RIPARAZIONE (Italian)
0 references
‘Silk Biomaterials’ (‘Silk’) is developing SILKGRAFT — Silk vascular Prostohesis (SVP), a device for the in vivo regeneration of blood vessels with diameter (I.D.) < 8MM. THE BLOOD VESSELS ARE THE COMPONENT OF THE CIRCULATORY SYSTEM WHICH ALLOWS THE TRANSPORT OF OXYGEN AND NUTRIENTS TO TISSUES AND ORGANS, AND THE REMOVAL OF CO2 AND CATARBOLITI. THE MAIN BLOOD VESSELS OF MID-/SMALL BLOOD (CORONARIES, PERIPHERAL ARTERIES AND CAROTID) MAY FACE CONDITIONS REQUIRING REPAIR. (English)
0 references
Identifiers
E59J17000670007
0 references